Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 145 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Ropeginterferon alfa-2b for polycythaemia vera without symptomatic splenomegaly	Ropeginterferon alfa 2-b (P-1101; AOP2014; Pegylated-Proline-interferon alpha-2b)	Polycythaemia vera	Haematological Cancer and Lymphomas	2019	View \| Download
Romiplostim for idiopathic thrombocytopenic purpura in adult patients who are refractory to other treatments	Romiplostim (Nplate; AMG-531)	Idiopathic thrombocytopenic purpura	Haematology	2019	View \| Download
Rivaroxaban for reducing the risk of major thrombotic vascular events in symptomatic peripheral arterial disease patients with a recent lower extremity revascularisation procedure	Rivaroxaban (Xarelto; BAY 59-7939)	Peripheral arterial disease (PAD)	Cardiovascular System	2019	View \| Download
Risdiplam for paediatric and adult patients with spinal muscular atrophy (SMA)	Risdiplam (RG-7916; RO-7034067; Evrysdi)	Spinal muscular atrophy (SMA)	Genetic Disorders , Musculoskeletal System	2019	View \| Download
Relatlimab in combination with nivolumab for advanced melanoma – second line	Nivolumab (Opdivo; BMS-936558; ONO-4538) , Relatlimab (BMS-986016; Anti-LAG-3)	Melanoma	Skin Cancer	2019	View \| Download
Ramucirumab in addition to erlotinib for EGFR mutation-positive metastatic non-small-cell lung cancer	Erlotinib (Tarceva; erlotinib hydrochloride) , Ramucirumab (Cyramza)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2019	View \| Download
Pioglitazone for sudden sensorineural hearing loss	Pioglitazone (Actos; AD-4833; pioglitazone hydrochloride)	Sudden sensorineural hearing loss	Ear Nose and Throat (ENT) , Neurology	2019	View \| Download
Pexidartinib for tenosynovial giant cell tumour	Pexidartinib (PLX3397)	Tenosynovial giant cell tumour (TGCT)	Oncology	2019	View \| Download
Pertuzumab and trastuzumab (fixed-dose combination) in addition to chemotherapy for breast cancer	Pertuzumab and Trastuzumab (Phesgo; RO7198574) (fixed dose combination: Trastuzumab; Pertuzumab)	Breast cancer	Breast Cancer	2019	View \| Download
Pemigatinib for locally advanced or metastatic, relapsed or refractory cholangiocarcinoma with FGFR2 fusion or rearrangement	Pemigatinib (INCB054828)	Cholangiocarcinoma	Gastrointestinal Cancer	2019	View \| Download